• CDC
  • Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

A Guide to Prescribing the Right Diabetes Device for your Patients, with DiabetesWise Pro Developer Korey Hood, PhD

Video

DiabetesWise Pro lets clinicians compare diabetes devices for a specific patient and provides the steps for ordering the device based on insurance type.

The DiabetesWise Pro website is an unbranded, unabiased tool for quick comparison of all the diabetes technology devices currently avaialable, from smart pens to insulin pumps.

The site allows clinicians to compare devices across basic details, such as affordability, data monitoring options, and vision/auditory/dexterity and then on patient considerations, such as active lifestyle, privacy, comfort, and need to avoid highs/lows.

Patient Care spoke recently with Stanford University professor Korey Hood, PhD, who led the Stanford team that developed the site. We aksed him to walk through a typical navigation path that a clinician might follow to compare diabetes devices, match a device to a specific patient, and initiate the prescription process.


For more of Patient Care's conversation with Dr Hood, see:

Diabetes Device Comparison Made Easy: The Story Behind DiabetesWise Pro

DiabetesWise Pro: Side-by-side, Feature-by-feature CGM Comparison, Plus More


Korey Hood, PhD, is a professor of pediatric endocrinology and of psychiatry and behavrioal sciences at Stanford Univesity, Stanford, CA. Hood also directs NIH- and foundation-funded clinical research focused on health and quality of life outcomes for persons living with diabetes. He has lived with type 1 diabetes since he was a young adult.


Related Videos
Where Should SGLT-2 Inhibitor Therapy Begin? Thoughts from Drs Mikhail Kosiborod and Neil Skolnik
© 2024 MJH Life Sciences

All rights reserved.